Abstract:AIM To observe whether the exogenous human vascular endothelial growth factor hVEGF can express and secrete endothelial growth factor EGF or not after it is guided in normal dermal fibroblasts which is the base of gene transfected artificial skin of tissue engineering as a new substitute for wound healing. METHODS This experiment was conducted in Jilin University from June 2001 to June 2005. ① The recombinant mammalian expression plasmid vector containing hVEGF cDNA pcDNA3.0-hVEGF165 was amplified in DH5a then purified and finally identified by agarose gel electrophoresis analysis after digestion with restriction endonuclease EcoRⅠand XbaⅠ.②Skin biopsies were obtained from two neonatal rabbits at the level of clean animal chipped into small pieces 0.3 cm in width. Dermal fibroblasts were isolated and cultured in vitro by digestion with collagenaseⅠ. Fibroblasts were transfected with the plasmids of pcDNA3.0-VEGF165 using lipo-mediated transfection and selected with G418 for 2 to 4 weeks. The positive clones of transfected cells were obtained and proliferated in vitro. ③The level of secreted VEGF165 protein in supernatant was determined with enzyme-linked immunosorbent assay ELISA The expression of VEGF165 mRNA in transfected cells was analyzed with in situ hybridization Flow cytometerFCM was used to detect cell cycle and apoptosis The ultrastructure of transfected dermal fibroblasts was observed with transmission electron microscopeTEM. RESULTS ①Two DNA segments about 5.4 kb and 0.57 kb in length were obtained after digestion with EcoRⅠand XbaⅠ. It was confirmed that the obtained vector was the recombinant plasmid pcDNA3.0-VEGF165. ②The G418-resistant colonies were pooled to generate the stable transfected cells in all 35 wells in 15 transfecting tests. It indicated that the pcDNA3.0-VEGF165 could be efficiently introduced into dermal fibroblasts using lipo-mediated transfection. ③When hVEGF165 detected with ELISA in cell culture there was a high level of hVEGF165 expressed by transfected fibroblasts in 24 hours (3 280±2 054 ng/L) which descended gradually in 48 and 72 hours ④ In situ hybridization analysis showed that there were several positive cells expressing hVEGF mRNA in transfected fibroblasts while a mass of positive cells expressing hVEGF mRNA were found in selected fibroblasts. The clones of pcDNA3.0-hVEGF165 transfected fibroblasts could be selected successfully after treated with G418 with 2-4 weeks. ⑤FCM analysis showed that the proportion of S phase-cells increased while that of G1 phase-cells and G2 phase-cells decreased in pcDNA3.0-hVEGF165 transfected fibroblasts. It indicated that there were enhancements of both DNA synthesis and cell proliferation in the transfected cells. The apoptosis ratios of fibroblasts increased gradually which was 1.26% 2.64% and 17.35% in the groups before transfection 2 days and 12 passages after transfection respectively. ⑥The ultrastructure changes of transfected cells analyzed by TEM included many microvilli on the membrane the nucleus in curved shapes numerous rough endoplasmic reticulum and mitochondria in the cytoplasm as well as some special enveloped granues near the membrane. CONCLUSION pcDNA3.0-hVEGF165 plasmids had been transfected into fibroblasts and high level of hVEGF165 had been expressed in the transfected cells in a short period. As a new cell source it shows a good foreground in the field of gene transfected artificial skin of tissue engineering and clinical therapy for ischemic diseases and wounds healing.

Cloning of human vascular endothelial growth factor cDNA and its expression in COS-7 cells

Hvegf165 Gene Clone and Its Expression in COS-7 Cells

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Recombinant Human Vascular Endothelial Growth Factor-C and Its Expression in vitro

Cloning, Expression and Activity Detection of Vascular Endothelial Growth Factor

Cloning and Expression of Vascular Endothelial Growth Factor 165 in E.coli

Cloning of cDNA Encoding Extra-Cellular Domain of Human VEGF Receptor KDR and Effect of Its Recombinant Protein on Endothelial Cell Proliferation and Angiogenesis

Construction of vascular endothelial growth factor 165 gene eukaryotic vectors for transfection of skeletal muscle cells

Molecular Cloning, Expression And Characterization Of Recombinant Human Vascular Endothelial Growth Factor 121

Construction of human eukaryotic expression plasmid vascular endothelial growth factor 165 and its expression in transfected vascular smooth muscles.

The Stable Expression of VEGF165 in Mammalian Cells

Gene Cloning of Soluble VEGF Receptor FLT-1 and the Effect of Its Recombinant Protein on Angiogenesis

Cloning of human lysosomal acid beta-glucosidase gene and its expression in COS7 cells]

Construction of a Eukaryotic Expression Vector Hvegf_(165)-Fused Hirudin/pcdna3.0 and Its Expression

Construction of hVEGF165 Recombinant Adenovirus Vector and Its Expression in HEK293 Cells

Effect of human VEGF165 in vitro on proliferation of vascular endothelial cells

Expression of human vascular endothelial growth factor gene transfected into rabbit dermal fibroblasts in vitro

[Construction of VEGF Eukaryotic Expression Vector and Its Expression in Endothelial Cells and Cardiac Myocytes In-Vitro].

Construction of Recombinant Adenovirus Coding for Vascular Endothelial Growth Factor Gene

Construction of the Eukaryotic Expression Plasmid of Human Vascular Endothelial Growth Factor Which is Advantageous to Wound Healing

Construction of Recombinant Adenoviruse Vector Containing Human Vascular Endothelial Growth Factor and Its Expression in Mesenchymal Stem Cells